Diagnóstico del Síndrome De Guillain Barre asociado a la infección por SARS-COV-2

Abstract

The pandemic caused by the COVID-19 infection has left a large number of sequelae in different organs and tissues, these sequelae not only occurred in the respiratory system, complications were also identified in the nervous system. The increase in cases of Guillain Barré syndrome during the emerging pandemic in 2020 gave rise to the possibility that SARS-CoV-2 is a trigger for neurological manifestations.Neurological clinical manifestations of the autoimmune type were reported, among which it was reported about patients with GBS linked to SARS-CoV-2. GBS is a polyneuropathy that affectsthe myelin sheath of the nerves, which is why it is considered demyelinating and has been related to infectious processes of viral and bacterial etiology, so it is possible that COVID-19 participates as a causative agent.Therefore, it seeks to collect information regarding the association between GBS and the SARS-CoV-2 virus as well as its symptoms, diagnosis and treatment